This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Early Netlist challenge to Samsung request for Rand terms rejected in US

By Melissa Ritti ( March 5, 2025, 17:50 GMT | Insight) -- A bid by Netlist for dismissal of a complaint by Samsung which seeks a determination of reasonable and nondiscriminatory, or Rand, terms for a license to a Netlist patent which may or may not be standard essential has been denied. Citing the existence of a global patent dispute between the parties, US District Judge Jennifer Hall found yesterday Samsung’s lawsuit plausibly alleges that if the claims of US Patent No. 11,880,319 read on memory functionality in Samsung’s products, the patent “is essential and must be licensed on Rand terms.”An amended complaint by Samsung Electronics Co., Ltd., Samsung Semiconductor, Inc., and Samsung Electronics America (Samsung, collectively) for a declaration they do not infringe a patent potentially essential to the Joint Electron Device Engineering Council, or JEDEC, standard is moving forward in the US....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections